DataMEDS AI

MEDS

Medical - Distribution · Healthcare

Price

$1.99

-0.65 (-24.62%)

Market Cap

$5.2M

Exchange

NASDAQ Capital Market

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Data as of Aug 9, 2026 · filings through Mar 31, 2026

Share count rising — dilution

+50.2% over 3y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 945K (2022) → 1.4M (2025)

DataMEDS AI, Inc. is a small healthcare technology company that focuses on using artificial intelligence to help with medical data and distribution-related services. The company operates in the medical distribution industry, which involves getting medicines, supplies, or health information to the right places and people. It targets healthcare providers, pharmacies, or similar customers in the healthcare sector.

DataMEDS AI generates revenue through its technology services or platform offerings, though the company is currently very early-stage and not yet profitable. Its financials show deeply negative margins, meaning it spends far more than it earns right now. The company appears to operate primarily in the United States and has a very small market presence, with a market cap near zero. The biggest risk facing DataMEDS AI is its severe cash burn — with an operating margin of nearly -400%, the company must raise new money or dramatically grow revenue to survive, making it a high-risk, speculative business at this stage.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-85.6% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+88.1% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Cash Runway

~0 months

$51,730 cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

DataMEDS AI has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

-12.0%

Thin — -12.0% gross margin

Operating Margin

-385.7%

Losing money on operations — -385.7%

ROCE

-45.3%

Weak — -45.3% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-33.3%

Shrinking sales (-33.3% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-99.2%

Burning cash (-99.2%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial